206 related articles for article (PubMed ID: 12954224)
1. Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides.
Cook RF; Cook SJ; Berger SL; Leroux C; Ghabrial NN; Gantz M; Bolin PS; Mousel MR; Montelaro RC; Issel CJ
Virology; 2003 Sep; 313(2):588-603. PubMed ID: 12954224
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.
Cook RF; Leroux C; Cook SJ; Berger SL; Lichtenstein DL; Ghabrial NN; Montelaro RC; Issel CJ
J Virol; 1998 Feb; 72(2):1383-93. PubMed ID: 9445039
[TBL] [Abstract][Full Text] [Related]
3. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.
Chen C; Li F; Montelaro RC
J Virol; 2001 Oct; 75(20):9762-70. PubMed ID: 11559809
[TBL] [Abstract][Full Text] [Related]
4. Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus.
Cook SJ; Cook RF; Montelaro RC; Issel CJ
Vet Microbiol; 2001 Mar; 79(2):93-109. PubMed ID: 11230932
[TBL] [Abstract][Full Text] [Related]
5. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
Lichtenstein DL; Issel CJ; Montelaro RC
J Virol; 1996 Jun; 70(6):3346-54. PubMed ID: 8648664
[TBL] [Abstract][Full Text] [Related]
6. Deep sequencing and variant analysis of an Italian pathogenic field strain of equine infectious anaemia virus.
Cappelli K; Cook RF; Stefanetti V; Passamonti F; Autorino GL; Scicluna MT; Coletti M; Verini Supplizi A; Capomaccio S
Transbound Emerg Dis; 2017 Dec; 64(6):2104-2112. PubMed ID: 28299895
[TBL] [Abstract][Full Text] [Related]
7. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
8. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
[TBL] [Abstract][Full Text] [Related]
9. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
[TBL] [Abstract][Full Text] [Related]
10. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.
Li F; Chen C; Puffer BA; Montelaro RC
J Virol; 2002 Feb; 76(4):1569-77. PubMed ID: 11799151
[TBL] [Abstract][Full Text] [Related]
11. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.
Payne SL; Pei XF; Jia B; Fagerness A; Fuller FJ
J Virol; 2004 Mar; 78(5):2478-85. PubMed ID: 14963146
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.
Maury W; Thompson RJ; Jones Q; Bradley S; Denke T; Baccam P; Smazik M; Oaks JL
J Virol; 2005 May; 79(9):5653-64. PubMed ID: 15827180
[TBL] [Abstract][Full Text] [Related]
13. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
[TBL] [Abstract][Full Text] [Related]
14. Reverse mutation of the virulence-associated S2 gene does not cause an attenuated equine infectious anemia virus strain to revert to pathogenicity.
Gao X; Jiang CG; Wang XF; Lin YZ; Ma J; Han XE; Zhao LP; Shen RX; Xiang WH; Zhou JH
Virology; 2013 Sep; 443(2):321-8. PubMed ID: 23763769
[TBL] [Abstract][Full Text] [Related]
15. Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.
Liang H; He X; Shen RX; Shen T; Tong X; Ma Y; Xiang WH; Zhang XY; Shao YM
Arch Virol; 2006 Jul; 151(7):1387-403. PubMed ID: 16502285
[TBL] [Abstract][Full Text] [Related]
16. Phorbol ester stimulation of equine macrophage cultures alters expression of equine infectious anemia virus.
Sellon DC; Walker KM; Russell KE; Perry ST; Fuller FJ
Vet Microbiol; 1996 Oct; 52(3-4):209-21. PubMed ID: 8972047
[TBL] [Abstract][Full Text] [Related]
17. Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity.
Tang YD; Na L; Fu LH; Yang F; Zhu CH; Tang L; Li Q; Wang JY; Li Z; Wang XF; Li CY; Wang X; Zhou JH
Virology; 2015 Feb; 476():364-371. PubMed ID: 25589239
[TBL] [Abstract][Full Text] [Related]
18. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
[TBL] [Abstract][Full Text] [Related]
19. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.
Li F; Leroux C; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
J Virol; 2000 Jan; 74(1):573-9. PubMed ID: 10590152
[TBL] [Abstract][Full Text] [Related]
20. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
Leroux C; Issel CJ; Montelaro RC
J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
